<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="4-part\PMC7302680\results\search\drugs\results.xml">
  <result pre="10.1097/MD.000000000002058320583 : 4900: Research ArticleObservational Study Efficacy and safety of" exact="telbivudine" post="treatment for the prevention of HBV perinatal transmission RenCuicuiMDaWangLiliMDbSunWeihuiMDcMaLeiMDcDongZhiMDcHaoAnhuaMDcZhouLinMDcLiFengzhuMDcMaWenjieMDd∗"/>
  <result pre="the journal. http://creativecommons.org/licenses/by-nc/4.0medi-99-e20583.pdf Abstract Abstract To observe the efficacy of" exact="telbivudine" post="in chronic hepatitis B (CHB) women with high viral"/>
  <result pre="A total of 87 patients were included. Forty-two patients received" exact="telbivudine" post="orally 600 mg per day and treatment initiated from 12"/>
  <result pre="both serum HBV DNA and ALT in patients who received" exact="telbivudine" post="were significantly decreased at the 12th week after delivery,"/>
  <result pre="(P &amp;lt; .01). No significant changes were observed in patients not receiving" exact="telbivudine" post="(P &amp;gt; .05). Serum HBV DNA and ALT levels at the"/>
  <result pre="ALT levels at the 12th week after delivery in the" exact="telbivudine" post="group were significantly lower than those of patients without"/>
  <result pre="telbivudine group were significantly lower than those of patients without" exact="telbivudine" post="(P &amp;lt; .01). The serum HBsAg-positive rate in neonates 7 months"/>
  <result pre="Both mental and physical development in neonates with exposure to" exact="telbivudine" post="during perinatal period were similar to those without telbivudine"/>
  <result pre="to telbivudine during perinatal period were similar to those without" exact="telbivudine" post="exposure. Keywords Hepatitis B virus long-term efficacy and safety"/>
  <result pre="Hepatitis B virus long-term efficacy and safety mother-neonatal transmission pregnancy" exact="telbivudine" post="1 Introduction Chronic hepatitis B virus (CHB) infection remains"/>
  <result pre="besides HBIg and HBV vaccination.[5] The previous study showed that" exact="telbivudine" post="(LdT) was effective to reduce serum HBV DNA in"/>
  <result pre="was mainly to evaluate the efficacy and safety profile of" exact="telbivudine" post="in pregnant women with high HBV load and the"/>
  <result pre="Table 1 Clinical characteristics of patients enrolled. 3.2 Efficacy of" exact="telbivudine" post="in mothers At the time of delivery, the mean"/>
  <result pre="infants in all groups at month 7. 3.4 Safety of" exact="telbivudine" post="in infants No significant difference was observed between infants"/>
  <result pre="indicated that their intelligence developments were not affected by perinatal" exact="telbivudine" post="exposure, compared with infants from control groups as shown"/>
  <result pre="and guidelines to improve MTCT prevention. Previous advances showed that" exact="telbivudine" post="had no effects on human nucleotides stability or DNA"/>
  <result pre="involving 3622 pregnant CHB women, showed that LdT, LAM, or" exact="tenofovir" post="was effective to reduce MTCT rate with no significant"/>
  <result pre="adverse maternal or fetal events.[19] Consistently, our study indicated that" exact="telbivudine" post="treatment during pregnancy in women with high viral load"/>
  <result pre="= polymerase chain reaction, SD = standard deviation, TDF =" exact="tenofovir" post="disoproxil. How to cite this article: Ren C, Wang"/>
  <result pre="Zhou L, Li F, Ma W. Efficacy and safety of" exact="telbivudine" post="treatment for the prevention of HBV perinatal transmission. Medicine."/>
  <result pre="of pegylated interferon monotherapy and de novo pegylated interferon plus" exact="tenofovir" post="combination therapy in patients with chronic hepatitis B. Infect"/>
  <result pre="[7]YiWLiMHXieYet al.Prospective cohort study on the efficacy and safety of" exact="telbivudine" post="used throughout pregnancy in blocking mother-to-child transmission of hepatitis"/>
  <result pre="Soc2018;7:290–5.28992071 [10]LimSSLiaoHTTsaiCYTelbivudine associated mitochondrial myopathy. Liver Int2018;38:1139.29570939 [11]ZhangHPanCQPangQet al.Telbivudine or" exact="lamivudine" post="use in late pregnancy safely reduces perinatal transmission of"/>
  <result pre="virus in real-life practice. Hepatology2014;60:468–76.25187919 [12]HuYXuCXuBet al.Safety and efficacy of" exact="telbivudine" post="in late pregnancy to prevent mother-to-child transmission of hepatitis"/>
  <result pre="prospective and open-label study for the efficacy and safety of" exact="telbivudine" post="in pregnancy for the prevention of perinatal transmission of"/>
  <result pre="B virus infection. J Hepatol2011;55:1215–21.21703206 [16]HanGRJiangHXYueXet al.Efficacy and safety of" exact="telbivudine" post="treatment: an open-label, prospective study in pregnant women for"/>
  <result pre="gestational stages for the prevention of mother-to-child transmission: Outcomes of" exact="telbivudine" post="treatment during pregnancy. Medicine (Baltimore)2016;95:e4847.27749537 [19]BrownRJMcMahonBJLokASet al.Antiviral therapy in"/>
  <result pre="[21]ZhouCYuYYangQet al.Motor development delay in offspring is associated with prenatal" exact="telbivudine" post="exposure. Medicine (Baltimore)2018;97:e0053.29489662"/>
 </snippets>
</snippetsTree>
